Burning feet at night, numbness that creeps up from the toes, or a pins-and-needles feeling that will not settle are among the most common ways type 2 diabetes announces the damage it has been doing quietly. Diabetic peripheral neuropathy is not a separate disease that happens to arrive alongside diabetes. It is nerve tissue responding to years of metabolic stress, and its timeline tracks the disease that produced it.
Among people with diabetes, 50% to 66% develop diabetic peripheral neuropathy at some point.1 The pattern over time is what makes the point most clearly: 10% to 20% already have it when diabetes is diagnosed, rising to 26% after five years and 41% after ten.1
Why it starts before the diagnosis does
That first figure deserves a second look. Between 10% and 20% of people already have measurable nerve involvement on the day they are told they have diabetes.1
Nerve injury does not wait for a lab value to cross a threshold. The metabolic process that damages nerves — chronically elevated insulin, glycation of proteins, oxidative stress and the microvascular changes that follow — is well underway during the years of insulin resistance that precede a diabetes diagnosis. By the time the diagnosis is made, that process has had a long run.
This is why insulin resistance is the more useful thing to measure and to act on. It is the upstream state, and it is present long before glucose is abnormal enough to be called diabetes.
The mechanism, briefly
Nerves are metabolically demanding and depend on a fine microvascular supply. Sustained hyperglycemia and hyperinsulinemia damage both the nerve fibers and the small vessels that feed them.
Glycation — sugar binding to proteins — stiffens tissue and generates advanced glycation end-products that drive inflammation. That inflammatory state is not confined to the nerve, which is why it shows up alongside other consequences of the same process. The relationship is set out in metabolic inflammation as a cause of insulin resistance.
The same mechanism explains why nerve pain and chronic pain more broadly cluster with metabolic disease, covered in insulin resistance and chronic pain.
Longest nerves first
Symptoms usually begin in the feet and move upward, and the hands are affected later. This is not coincidence: the longest nerve fibers are the most vulnerable to a metabolic and microvascular insult, because they have the most distance to supply and maintain.
That is also why symmetry matters diagnostically. A symmetrical, length-dependent pattern points toward a metabolic cause. Pain confined to one limb or one nerve distribution suggests something else — compression, injury, or a different process — and warrants a different work-up.
What actually changes the trajectory
Treating the pain and treating the cause are different projects, and both are legitimate. Medications can make symptoms tolerable. They do not slow the underlying process.
What addresses the process is improving insulin sensitivity and reducing the glycemic and inflammatory load the nerves are exposed to. In practical terms that means the composition of the diet more than its calorie count — the role of refined grains and of omega-6-rich vegetable oils, and the foods that move the other way, described in foods that improve insulin sensitivity.
The honest framing is remission rather than cure. Type 2 diabetes can be driven into remission, and remission can be lost — it describes a state that is being maintained, not a condition that has been permanently removed. Where nerve damage is concerned, some is recoverable and some is not; the realistic goals are halting progression, reducing pain, and protecting the feet you still have sensation in.
A caution about medication during improvement
As insulin sensitivity improves, the dose of glucose-lowering medication that was appropriate before can become too much, and the risk of hypoglycemia rises. This is a predictable consequence of things going well.
It is also the reason metabolic change should be made with your prescriber informed and involved. Never stop, reduce or alter a prescribed medication on your own — that decision belongs to the physician managing it, working from your actual numbers.
Why sensation loss is the urgent part
Pain is what brings people in. Numbness is the more dangerous finding.
Once protective sensation is lost, an injury can go unnoticed long enough to become a serious problem, and reduced circulation slows healing. Daily foot inspection and prompt attention to any wound are not minor advice in this setting.
Care in St. Louis
Reverse Diabetes MD is at 4477 Woodson Rd, Suite 209, St. Louis, MO 63134, with Dr. Gurpreet Singh Padda, MD, MBA, MHP as Medical Director. Call (314) 481-5000 or email info@reversediabetes.md.
Background on the practice’s approach is on the type 2 diabetes page and in why we care. You can read about the physician on the Dr. Padda page, browse further reading on the blog, or reach the office through the contact page.
Frequently asked questions
How common is nerve damage in type 2 diabetes?
Between 50% and 66% of people with diabetes develop diabetic peripheral neuropathy at some point, and 10% to 20% already have it at diagnosis.1 The upstream process is explained in what exactly is insulin resistance.
Can diabetic neuropathy be reversed?
Some early nerve dysfunction improves when the metabolic driver is addressed, and established damage may not. The realistic aim is to stop progression and reduce symptoms rather than to promise reversal.
My blood sugar is only slightly high. Am I at risk?
Nerve injury tracks the insulin-resistant state that precedes a diabetes diagnosis, which is why a portion of people already have neuropathy when they are first diagnosed.1 See insulin resistance and chronic pain.
Why does it start in the feet?
The longest nerve fibers are the most vulnerable to metabolic and microvascular injury, so symptoms typically appear in the feet first and move upward, with the hands involved later.
Should I change my diabetes medication if my numbers improve?
Not on your own. Improving insulin sensitivity can make a previously appropriate dose excessive and raise the risk of hypoglycemia, so any change must be made by the physician who prescribed it.
Where is the practice located?
4477 Woodson Rd, Suite 209, St. Louis, MO 63134. Call (314) 481-5000, or use the contact page.
Sources
- Bodman MA, Dreyer MA, Varacallo MA. Diabetic Peripheral Neuropathy. StatPearls. NBK442009
